GE HealthCare Technologies Inc. $GEHC Shares Sold by Great Lakes Advisors LLC

Key Points

• Great Lakes Advisors LLC has decreased its holdings in GE HealthCare Technologies by 2.0%, now owning 223,455 shares valued at about $18.04 million.
• The company recently announced a quarterly dividend of $0.035 per share, reflecting an annualized yield of 0.2%.
• Analysts have varying ratings for GE HealthCare Technologies, with a consensus rating of "Moderate Buy" and a price target averaging at $88.40.

Great Lakes Advisors LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 2.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 223,455 shares of the company's stock after selling 4,452 shares during the quarter. Great Lakes Advisors LLC's holdings in GE HealthCare Technologies were worth $18,035,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Knuff & Co LLC increased its position in shares of GE HealthCare Technologies by 1.5% during the 1st quarter. Knuff & Co LLC now owns 10,276 shares of the company's stock worth $829,000 after purchasing an additional 150 shares during the last quarter. Graypoint LLC increased its position in shares of GE HealthCare Technologies by 5.7% during the 1st quarter. Graypoint LLC now owns 3,028 shares of the company's stock worth $244,000 after purchasing an additional 162 shares during the last quarter. Ferguson Wellman Capital Management Inc. increased its position in shares of GE HealthCare Technologies by 3.2% during the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company's stock worth $431,000 after purchasing an additional 166 shares during the last quarter. Spire Wealth Management increased its position in shares of GE HealthCare Technologies by 5.2% during the 1st quarter. Spire Wealth Management now owns 3,367 shares of the company's stock worth $272,000 after purchasing an additional 166 shares during the last quarter. Finally, Freestone Capital Holdings LLC increased its position in shares of GE HealthCare Technologies by 5.1% during the 1st quarter. Freestone Capital Holdings LLC now owns 3,454 shares of the company's stock worth $279,000 after purchasing an additional 169 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 2.6%

GE HealthCare Technologies stock traded up $1.97 during midday trading on Thursday, reaching $77.96. The company's stock had a trading volume of 4,355,639 shares, compared to its average volume of 2,891,212. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The company has a market cap of $35.59 billion, a P/E ratio of 15.98, a P/E/G ratio of 2.90 and a beta of 1.13. The business has a 50-day simple moving average of $74.45 and a 200-day simple moving average of $73.76.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. During the same period last year, the firm earned $1.00 earnings per share. GE HealthCare Technologies's quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GEHC shares. Citigroup raised their price objective on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Zacks Research raised GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Morgan Stanley decreased their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $88.40.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.